Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome.

Humans Li-Fraumeni Syndrome / genetics Immune Checkpoint Inhibitors / therapeutic use Female Male Adult Middle Aged Young Adult

Journal

JCO precision oncology
ISSN: 2473-4284
Titre abrégé: JCO Precis Oncol
Pays: United States
ID NLM: 101705370

Informations de publication

Date de publication:
Jun 2024
Historique:
medline: 7 6 2024
pubmed: 7 6 2024
entrez: 7 6 2024
Statut: ppublish

Résumé

A case series evaluating efficacy and safety of immune checkpoint blockade in Li-Fraumeni syndrome.

Identifiants

DOI: 10.1200/PO.24.00139 PMID: 38848519
pubmed: 38848519
doi: 10.1200/PO.24.00139
doi:

Substances chimiques

Immune Checkpoint Inhibitors 0

Types de publication

Journal Article Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2400139

Auteurs

Michele Bottosso (M)

INSERM Unit U981, Gustave Roussy Cancer Campus, Villejuif, France.
Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
ORCID: 0000-0002-8098-1819

Benjamin Verret (B)

INSERM Unit U981, Gustave Roussy Cancer Campus, Villejuif, France.
Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France.

Olivier Caron (O)

Oncogenetic Department, Institut Gustave Roussy, Villejuif, France.
ORCID: 0000-0001-8934-2071

Nadim Hamzaoui (N)

INSERM U1016, CNRS UMR8104, Université Paris Cité, CARPEM, Institut Cochin, Paris, France.
Department of Molecular Biology, Fédération de Génétique et Médecine Génomique, Cochin Hospital, Université Paris Cité, APHP Centre, Paris, France.
ORCID: 0000-0003-4630-9401

Eric Pasmant (E)

INSERM U1016, CNRS UMR8104, Université Paris Cité, CARPEM, Institut Cochin, Paris, France.
Department of Molecular Biology, Fédération de Génétique et Médecine Génomique, Cochin Hospital, Université Paris Cité, APHP Centre, Paris, France.
ORCID: 0000-0002-1881-8762

Francois-Xavier Danlos (FX)

Drug Development Department, Gustave Roussy, Villejuif, France.
INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France.
Faculté de Médecine, Université Paris Saclay, Gif-sur-Yvette, France.
ORCID: 0000-0003-1880-064X

Pascaline Boudou-Rouquette (P)

INSERM U1016, CNRS UMR8104, Université Paris Cité, CARPEM, Institut Cochin, Paris, France.
Department of Medical Oncology, Cochin Hospital, Paris Cancer Institute CARPEM, Université Paris Cité, APHP Centre, Paris, France.

Arunya Srikaran (A)

Department of Medical Oncology, Cochin Hospital, Paris Cancer Institute CARPEM, Université Paris Cité, APHP Centre, Paris, France.

Hélène Blons (H)

Department of Molecular Biology, Fédération de Génétique et Médecine Génomique, European Geoges Pompidou Hospital, Université Paris Cité, APHP Centre, Paris, France.
ORCID: 0000-0002-0572-8426

Valentina Guarneri (V)

Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
ORCID: 0000-0002-2375-8397

Sherene Loi (S)

Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
The Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne, VIC, Australia.
ORCID: 0000-0001-6137-9171

Fabrice André (F)

INSERM Unit U981, Gustave Roussy Cancer Campus, Villejuif, France.
Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France.
ORCID: 0000-0001-5795-8357

Camille Tlemsani (C)

INSERM U1016, CNRS UMR8104, Université Paris Cité, CARPEM, Institut Cochin, Paris, France.
Department of Medical Oncology, Cochin Hospital, Paris Cancer Institute CARPEM, Université Paris Cité, APHP Centre, Paris, France.
ORCID: 0000-0002-3342-1704

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Efficacy and Safety of Immune Checkpoint...
questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Maladies métaboliques › Troubles dus à un défaut de réparation de l'ADN › Syndrome de Li-Fraumeni › Efficacy and Safety of Immune Checkpoint...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antinéoplasiques › Antinéoplasiques immunologiques › Inhibiteurs de points de contrôle immunitaires › Efficacy and Safety of Immune Checkpoint...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Efficacy and Safety of Immune Checkpoint...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Efficacy and Safety of Immune Checkpoint...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Jeune adulte › Efficacy and Safety of Immune Checkpoint...